Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere
L

Lenskart Solutions Ltd

Complete IPO details, including price band, financials, subscription status, and key insights.

Participate in the Lenskart Solutions Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.

IPO Snapshot

Key metrics and details at a glance.

Price Band

₹402

Per Share

Lot Size

37 Shares

Minimum Investment

₹14,874

Issue Size

₹7,278.02 Cr

Face Value

₹2

Per Share

IPO Type

Book Building

Retail Quota

10%

QIB Quota

75%

NII Quota

15%

IPO Timeline

Important dates for your applying strategy.

IPO Opens31 Oct
IPO Closes4 Nov
Basis of Allotment6 Nov
Refund Initiation7 Nov
Shares Credited7 Nov
Listing Date10 Nov
IPO Process Completed

Subscription Status

Live demand across investor categories.

Track real-time subscription levels:

*Real-time data subject to exchange updates

Qualified Institutional Buyers (QIB)40.35x
Non-Institutional Investors (NII)18.23x
Retail Individual Investors (RII)7.54x
Overall Subscription28.26x

Lenskart Solutions Ltd

Business model, operations, and market positioning.

Promoter Holding (Pre-Issue)

19.9%

Promoter Holding (Post-Issue)

17.71%

Issue Type

Book Building

ISIN

INE956O01016

About the Company

We are a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products. We primarily sell prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories, under multiple brands and sub-brands. Our focus markets are India, Southeast Asia, Japan and the Middle East. We operate frame and lens design and eyeglass manufacturing facilities at two locations in India, supplemented by regional facilities in Singapore and the United Arab Emirates. We have an established presence across channels, including our websites, mobile applications and retail stores.

Industry Overview

India is one of the fastest-growing retail markets, driven by urbanisation, rising disposable incomes, and a technology-proficient young population. The eyewear market in India is projected to expand at approximately 13% CAGR, reaching Rs.1,483 billion (approximately US$17.2 billion) by the Financial Year 2030. Prescription eyeglasses dominate with approximately 73% of market value. The rising global prevalence of refractive errors is driven by evolving lifestyles, coupled with an ageing population. Organised retail channels, driven by efficient supply chains and improved consumer experience, are projected to account for approximately 31% of India's eyewear market by the Financial Year 2030.

Company History

Our Company was originally incorporated as `Valyoo Technologies Private Limited', as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated May 19, 2008, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana at New Delhi. Thereafter, the name of our Company was changed to `Lenskart Solutions Private Limited' pursuant to a fresh certificate of incorporation dated May 19, 2015, issued by the Registrar of Companies, Delhi and Haryana, at New Delhi (the "RoC"). Subsequently, our Company was converted to a public limited company and the name of our Company changed to `Lenskart Solutions Limited' pursuant to a resolution passed by our Board on May 21, 2025, and resolution passed by our Shareholders on May 30, 2025, and a fresh certificate of incorporation dated June 16, 2025, was issued by the RoC.

Products & Services

  • The Company is a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products.

Growth Strategy

  • Increase Markets' Penetration and, Expand Customer Access Across Channels.
  • Strengthen Manufacturing and Supply Chain Capabilities.
  • Continue to Innovate and Expand our Product Portfolio.
  • Invest in New Technologies.
  • Continue to Enhance Customer Experience.
  • Continue to strengthen our brand across our markets.

Customer Base

Wholesaler and Retailer

Financial Performance

Revenue, profit after tax and total assets across the last 3 reported financial years.

Consolidated figures
Financial Performance Categories

Revenue

+62.4%vs FY24

Amount in ₹ crore

5,428
6,653
8,814
FY24FY25FY26

Profit After Tax (PAT)

Amount in ₹ crore

-17.5
296
494
FY24FY25FY26

Total Assets

+50.6%vs FY24

Amount in ₹ crore

9,691
10,668
14,595
FY24FY25FY26

Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.

Objects of the Issue

How the company plans to utilize IPO proceeds.

Use of Proceeds

The funds raised through this IPO will be used for:

Initial public offering of up to 181,063,669 equity shares of face value of Rs.2/- each ("Equity Shares") of Lenskart Solutions Limited (the "Company" or the "Issuer") for cash at a price of Rs.402 per equity share of face value of Rs.2/- each (including a share Premium of Rs.400 per Equity Share) ("Offer Price"), aggregating up to Rs.7278.02 crores comprising a fresh issue of up to 53,501,096 equity shares of face value of Rs.2/- each, aggregating up to Rs.2150.00 crores by the company ("Fresh Issue") and an offer for sale of up to 127,562,573 equity shares of face value of Rs.2/- each, aggregating up to Rs.5128.00 crores ("Offered Shares") by Certain Shareholders ("(Selling Shareholders") (such sale, the "Offer for sale", and together with the fresh issue, the "Offer"). The offer includes a reservation of 391,644 equity shares of face value of Rs.2/- each, aggregating up to Rs. 15 crores (constituting up to 0.02% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute 10.44% and 10.41% of the post-offer paid-up equity share capital of the company, respectively. The face value of equity shares is Rs.2 each. The offer price is 201 times the face value of the equity shares. The company, in consultation with the brlms, may consider a pre-ipo placement of specified securities aggregating up to Rs.430.00 crores, prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the of the securities contracts (regulation) rules, 1957, as amended (the "scrr"). The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer. The company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result in listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if Undertaken). A discount of Rs. 19 per equity share is being offered to eligible employees bidding in the employee reservation portion.

*Subject to approvals and market conditions.

Strengths & Risks

Key competitive advantages and factors to consider before investing.

Strengths and Risk Factors
  • Centralized Supply Chain and Automated Manufacturing.
  • In-House Frame and Lens Engineering and Manufacturing Capabilities.
  • Customer-Focused Product Design Capabilities.
  • Lenskart Brand and Portfolio of Owned Sub-brands.
  • Technology First Approach to Customer Experience and Operational Efficiency.
  • The company's cost of raw materials consumed constitutes a significant portion of its expenses (amounting to Rs.4,673.39 million, or 25.45% and Rs.16,229.74 million, or 24.52%, of the company's total expenses in the three months ended June 30, 2025 and the Financial Year 2025, respectively) and delays, interruptions or reduction in the supply of raw materials to manufacture the company's prescription eyeglasses or fluctuations in the prices of its raw materials could adversely affect the company's business, results of operations, financial condition and cash flows.
  • The company manufacture some of its frames in, and import some of the company's raw materials from, the People's Republic of China, including through import of frames through Baofeng Framekart Technology Limited, the company's Joint Venture. Any delay, interruption or reduction in the supply of such frames or other raw materials could adversely affect its business, financial condition, results of operations and cash flows.
  • An inability to maintain or improve the company's capacity utilization levels at the company's manufacturing facilities could have an adverse effect on its business, results of operations, financial condition and cash flows.
  • The Directorate of Enforcement, Gurugram under the Foreign Exchange Management Act, 1999, requested the company for certain information and documents. While the company has provided such requested documents, The company cannot assure you that no regulatory or other actions will be initiated against the Company in the future, in relation to such orders, which could adversely affect its business, reputation, results of operations, financial condition and cash flows.
  • The company's manufacturing facilities are subject to environmental, health, and safety laws and regulations that impose significant compliance costs and liabilities on the company's operations, and any non-compliance or violation could expose the company to legal actions, penalties, and reputational harm.

Frequently Asked Questions

01

What is the minimum investment required to apply for this IPO?

The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02

How is IPO allotment decided?

IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.
03

When will I know if shares are allotted to me?

Allotment status is usually finalized a few days after the IPO closes. Once finalized, shares are either credited to your Demat account (if allotted) or the blocked funds are released back to your bank account.
04

Can I modify or cancel my IPO application?

Yes, you can modify or cancel your IPO application anytime before the IPO closing date. Changes can be made through your Alice Blue account, subject to exchange cut-off timings.
05

What happens if the IPO is oversubscribed?

If the IPO receives more applications than the number of shares available, it is considered oversubscribed. In such cases, allotment in the retail category is done on a proportionate or lottery basis, and not all applicants may receive shares.